National Research (NR1A) Stock Price & Analysis
NR1A Stock Chart & Stats
- Day’s Range
- EUR 20.80 - EUR 20.80
- 52-Week Range
- EUR 9.65 - EUR 21.20
- Previous Close
- EUR 21.20
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 473.07M
- Enterprise Value
- EUR 563.06M
- Total Cash (Recent Filing)
- EUR 3.63M
- Total Debt (Recent Filing)
- EUR 102.90M
- Price to Earnings (P/E)
- 89.5
- Beta
- 0.38
- Next Earnings
- Feb 16, 2027 (Est.)
- EPS Estimate
- 0.21
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.72%
Bulls Say, Bears Say
Bulls Say
Recurring Contract Growth
Double-digit growth in recurring contract value indicates expanding customer commitments across multiple product portfolios. This recurring base can improve revenue visibility, support efficient planning, and provide a durable foundation for continued growth as bookings convert into recognized revenue.
Healthcare Data And AI Advantage
A large, healthcare-specific data history can strengthen the relevance of NRC’s analytics and AI outputs versus generic tools. Applying that data across experience, workforce, and market workflows may deepen customer value, improve retention, and support product differentiation.
Positive Cash Generation
Meaningful operating and free cash flow shows that the business continues to convert operations into cash despite weaker reported earnings. This supports ongoing investment in products and customer delivery, while also providing some internal capacity to address debt and other capital needs.
Bears Say
Deteriorated Balance Sheet
Higher debt combined with negative equity materially reduces financial flexibility and increases the importance of sustained cash generation. The changed capital structure can constrain investment choices, limit resilience during weaker performance, and make deleveraging more difficult.
Profitability Compression
The sharp decline in net and operating margins indicates that revenue growth has not translated into comparable earnings power. If profitability remains below historical levels, weaker internal funding, reduced operating resilience, and less capacity to absorb investment or cost pressures could persist.
Financial Leadership Transition
Combining the CEO and interim principal financial officer roles concentrates leadership responsibility during a period when capital allocation and financial oversight are especially important. Until a permanent CFO is appointed, the transition may create execution and stewardship risk.
National Research News
NR1A FAQ
What was National Research’s price range in the past 12 months?
What is National Research’s market cap?
When is National Research’s upcoming earnings report date?
How were National Research’s earnings last quarter?
Is National Research overvalued?
Does National Research pay dividends?
What is National Research’s EPS estimate?
How many shares outstanding does National Research have?
What happened to National Research’s price movement after its last earnings report?
Which hedge fund is a major shareholder of National Research?
What is the TipRanks Smart Score and how is it calculated?
National Research Stock Smart Score
Company Description
National Research
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green
- Employees
- 357
- Website
- nrchealth.com
- Address
- 1245 Q Street, Lincoln, NE, 68508, US
National Research (NR1A) Earnings & Revenues
NR1A Earnings Call
Earnings Call SentimentPositive
The call was broadly positive. NRC Health reported 11% TRCV growth, solid revenue momentum despite a revenue-recognition headwind, strong pipeline and sales-activity growth, progress on the Landmark implementation, and continued product and AI innovation. The main challenges were lower year-over-year EBITDA, a decline in average deal size, temporary uncertainty following the Qualtrics and Press Ganey transaction, and unusual tax and accounting effects. Highlights significantly outweighed the lowlights.
View all DE:NR1A earnings summariesNR1A Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 1 | 4 |
| Technical Analysis | 4 | 1 | 4 |
| Moving Averages | 12 | 0 | 0 |
